About Matthew Goldman
Form D filings for Micron Biomedical in 2024 list Matthew Goldman as director.
Matthew Goldman first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Matthew Goldman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matthew Goldman works with at each company, as listed on that company's latest Form D.
Micron Biomedical, Inc. · Form D, Dec 26, 2024
MP
Mark Prausnitz
Director
HS
Henry Sebastien
Executive Vice President, Head of Technical Operations
DM
Devin McAllister
Executive Vice President, Chief Technology Officer
IM
Idean Marvasty
Chief Financial Officer
BB
Brian Bernick
Director
BB
Bas Van Buijtenen
Director
SD
Steve Damon
Chief Executive Officer and director
LA
Labeeb Abboud
Director